Transcatheter-based aortic valve replacement vs. isolated surgical aortic valve replacement in 2020

Article Cardiac & Cardiovascular Systems

2021 ESC/EACTS Guidelines for the management of valvular heart disease Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)

Alec Vahanian et al.

EUROPEAN HEART JOURNAL (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Catherine M. Otto et al.

Summary: Supplemental digital content is available in the text.

CIRCULATION (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Impact of the COVID-19 pandemic on cardiovascular mortality and catherization activity during the lockdown in central Germany: an observational study

Holger M. Nef et al.

Summary: During the COVID-19 lockdown period in central Germany, cardiovascular mortality significantly increased while catheterization activities decreased. Further investigations are needed to understand the mechanisms behind these observations.

CLINICAL RESEARCH IN CARDIOLOGY (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Aortic valve replacement in Germany in 2019

Luise Gaede et al.

Summary: In 2019, in Germany, the in-hospital mortality of patients undergoing TV-TAVI and iSAVR was similar, with both procedures showing lower mortality ratios compared to the previous year, indicating technical improvements in both therapies.

CLINICAL RESEARCH IN CARDIOLOGY (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Outcomes 2 Years After Transcatheter Aortic Valve Replacement in Patients at Low Surgical Risk

Martin B. Leon et al.

Summary: In low surgical risk patients with symptomatic severe aortic stenosis, the PARTNER 3 trial showed superiority of transcatheter aortic valve replacement (TAVR) over surgery for the primary endpoint at 1 year. However, at 2 years, differences in death and stroke between TAVR and surgery were no longer significant, and TAVR patients had an increased risk of valve thrombosis.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Transcatheter Aortic Valve Implantation (TAVI) Versus Surgical Aortic Valve Replacement for Aortic Stenosis (SAVR): A Cost-Comparison Study

Karan K. Shah et al.

Summary: Comparative costing study using real-world data shows that short-term healthcare costs are lower for patients with aortic stenosis undergoing TAVI compared to SAVR. TAVI also has shorter hospital stays in intensive care and overall, suggesting potential cost savings from wider implementation of TAVI programs in hospitals across Australia.

HEART LUNG AND CIRCULATION (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems